Clinical Trial Update: Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing erlotinib intercalated with chemotherapy versus erlotinib alone as first-line treatment in stage IIIB/IV non-small cell lung cancer with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Xinjiang Medical University | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN